Planning Target Volume (PTV) Margin Determination from Marker-Based Setup and The ExacTrac 6D X-ray IGRT System in Prostate Cancer Patients

Authors

  • Siwadol Pleanarom Faculty of Medicine, Ramathibodi Hospital, Mahidol University
  • Lalida Tuntipumiamorn Department of Radiology, Faculty of Medicine, Siriraj Hospital, Mahidol University
  • Pittaya Dankulchai Department of Radiology, Faculty of Medicine, Siriraj Hospital, Mahidol University

Keywords:

Fiducial marker, Prostate cancer, PTV margin, Systemic error, VMAT

Abstract

Background: In radiation therapy, setup uncertainty of patients affect the expected treatment outcome and the addition of PTV margin is able to improve treatment accuracy. Objective: To evaluate setup variations and calculated optimal PTV margins for prostate VMAT setup using the ExacTrac image guided system with implanted fiducial marker registration and cone beam computed tomography. Materials and methods: A total number of 923 x-ray pair images and 271 CBCT images from 28 prostate VMAT patients treated with TrueBeamSTx were observed. By daily online localization, the corrections determined from initial laser setup, from the ExacTrac image system, and from CBCT were accumulated. Positioning differences based on fiducial markers registration between Digitally Reconstructed Radiography (DRR) images with the ExacTrac system and internal anatomy matching from CBCT were measured in rightleft (RL), supero-inferior (SI) and antero-posterior (AP) directions. The systematic (Σ) and random (σ) errors were calculated and determined PTV margin using van Herk margin formula (2.5Σ + 0.7σ). Results: The setup uncertainty from laser alignment was 2.65±2.66 mm, 2.96±2.65 mm and 4.83±4.89 mm in right-left (RL), supero-inferior (SI) and antero-posterior (AP) direction, respectively. With marker registration, these uncertainties were reduced to be 0.64±0.77, 0.81±0.95, and 0.90±1.32 mm and the residual error, when rechecked with soft tissue matching from CBCT, was still be 0.65±1.64, 0.80±1.99 and 0.90±2.01 mm in RL, SI and AP directions, respectively. The PTV margins based on implanted markers and ExacTrac daily online correction were calculated to be 1.46, 1.86 and 2.11 mm. in RL, SI and AP directions, respectively. Conclusion: Frequent CBCT imaging verification presented a limitation in patient dose. Using the ExacTrac x-ray system together with fiducial markers was found to be effective tool for daily setup verification. However, the optimal PTV margin was strongly suggested to assess from both the inter and intrafractional setup deviations.

References

Balter JM, Lam KL, Sandler HM, Littles JF, Bree RL, Ten Haken RK. Automated localization of the prostate at the time of treatment using implanted radiopaque markers: technical feasibility. Int J Radiat Oncol Biol Phys 1995;33:1281–86.

Langen KM, Pouliot J, Anezinos C, Aubin M, Gottschalk AR, Hsu IC, et al. Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2003;57:635–44.

Wong JR, Gao Z, Uematsu M, Merrick S, Machernis NP, Chen T, et al. Interfractional prostate shifts: review of 1870 computed tomography (CT) scans obtained during image-guided radiotherapy using CT-on-rails for the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 2008;72:1396–401.

Nijkamp J, Pos FJ, Nuver TT, de Jong R, Remeijer P, Sonke JJ, et al. Adaptive radiotherapy for prostate cancer using kilovoltage cone-beam computed tomography: first clinical results. Int J Radiat Oncol Biol Phys 2008;70:75–82.

Yin FF, Wong J, Balter J, Benedict S, Bissonette JP, Craig T et al. The role of in room kV x-ray imaging for patient setup and target localization. AAPM Report No.104. College Park, MD: AAPM; 2009.

Willoughby TR, Kupelian PA, Pouliot J, Shinohara K, Aubin M, Roach M, et al. Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys. 2006;65:528–34.

van Herk M, Remeijer P, Rasch C, Lebesque JV. The Probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 2000;47:1121-35.

van Herk M, Remeijer P, Lebesque JV. Inclusion of geometric uncertainties in treatment plan evaluation. Int J Radiat Oncol Biol Phys 2002;52:1407-22.

Poggi MM, Gant DA, Sewchand W, Warlick WB. Marker seed migration in prostate localization. Int J Radiat Oncol Biol Phys 2003;56:1248-51.

Alonso-Arrizabalaga S, Brualla González L, Roselló Ferrando JV, Pastor Peidro J, López Torrecilla J, Planes Meseguer D, et al. Prostate planning treatment volume margin calculation based on the ExacTrac x-ray 6D image-guided system: margins for clinical various clinical implementations. Int J Radiat Oncol Biol Phys 2007;69:936-43.

Kim JY, Chang SK and Shin HS. Setup variations and tumor margins using the ExacTrac x-ray 6D in prostate radiotherapy. World Congress on Medical Physics and Biomedical Engineering, September 7-12, 2009, Munich, Geramany. IFME proceedings, 2009;25:887-9.

Chi C, Tazi A, Fang DX, Ianuzzi C. Study of ExacTrac x-ray 6D IGRT setup uncertainty for marker-based prostate IMRT treatment. J Appl Clin Med Phys 2012;12:35-42.

Litzenberg DW, Balter JM, Hadley SW, Sandler HM, Willoughby TR, Kupelian PA, et al. Influence of intrafraction motion on margins for prostate radiotherapy. Int J Radiat Oncol Biol Phys 2006;65:548-53.

Downloads

Published

2017-06-29

How to Cite

1.
Pleanarom S, Tuntipumiamorn L, Dankulchai P. Planning Target Volume (PTV) Margin Determination from Marker-Based Setup and The ExacTrac 6D X-ray IGRT System in Prostate Cancer Patients. J Thai Assn of Radiat Oncol [Internet]. 2017 Jun. 29 [cited 2024 Dec. 21];23(1):13-8. Available from: https://he01.tci-thaijo.org/index.php/jtaro/article/view/203058

Issue

Section

Original articles